Security key
10501E201
BRAINSTORM CELL THERAPEUTICS - COM NEW (BCLI)
CUSIP: 10501E201
Q3 2023 13F Holders as of 30 Sep 2023
- Security type / class
- Equity / COM NEW
- Total 13F shares
- 4,633,811
- Total 13F value
- $928,378
- Share change
- -832,745
- Put/Call ratio
- 31%
- SEC-reported price per share
- $0.20
- Number of holders
- 51
- Value change
- -$3,135,364
- Number of buys
- 24
- Number of sells
- 22
Open additional details 1 more signal available
Report period
Q3 2023
Institutions
51
Top holders
10
BCLI full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q4 2023
Previous quarter: Q2 2023
BRAINSTORM CELL THERAPEUTICS INC. SEC filings
BRAINSTORM CELL THERAPEUTICS INC. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 10501E201
Recent filing periods:
Ownership snapshot
Top reported holders of BCLI - BRAINSTORM CELL THERAPEUTICS - COM NEW (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Sankesh Abbhi
Disclosed value leader
Sankesh Abbhi
Comparable rows
0/15
Latest evidence
30 Jun 2023
3/4/5
13F
Highest disclosed value: $3,860,181
15 rows are not safely comparable across share classes.
Showing 1-6 of 15 holder rows.
Quick read
Sankesh Abbhi has the largest disclosed position value at $3.86M.
0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Sankesh Abbhi's linked filing trail.
Disclosed position value
Top 5
Sankesh Abbhi
$3.86M
VANGUARD GROUP INC
$2.93M
AIGH Capital Management LLC
$1.46M
SUSQUEHANNA INTERNATIONAL GROUP, LLP
$1.04M
BlackRock Finance, Inc.
$1M
Value bars compare disclosed positions; verify each figure against the linked filing evidence.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Sankesh Abbhi |
3/4/5
Director
|
—
class O/S missing
|
$3,860,181
2,175,853 shares
|
— | 10 Dec 2021 |
| VANGUARD GROUP INC |
13F
Company
|
—
class O/S missing
|
$2,932,019
1,423,310 shares
|
— | 30 Jun 2023 |
| AIGH Capital Management LLC |
13F
Company
|
—
class O/S missing
|
$1,458,964
708,235 shares
|
— | 30 Jun 2023 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
Company
|
—
class O/S missing
|
$1,041,946
505,799 shares
|
— | 30 Jun 2023 |
| BlackRock Finance, Inc. |
13F
Company
|
—
class O/S missing
|
$1,000,057
485,464 shares
|
— | 30 Jun 2023 |
| ABNER HERRMAN & BROCK LLC |
13F
Company
|
—
class O/S missing
|
$577,000
280,000 shares
|
— | 30 Jun 2023 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q3 2023
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
51
Shares
4,633,811
Rows available
51
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q3 2023 vs Q2 2023 Across Filers
Q2 2023 holders
56
Q3 2023 holders
51
Holder diff
-5
| Investor | Q2 2023 Shares | Q3 2023 Shares | Share Diff | Share Chg % | Q2 2023 value | Q3 2023 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend